The FDA has greenlit multiple phase III clinical trials investigating Urolithin A’s role in healthy aging. This marks a significant milestone in longevity research, with studies set to examine effects on muscle function, cognitive health, and metabolic markers in aging populations. Leading research institutions including Stanford and Johns Hopkins are participating in these groundbreaking studies.